This new drug could break cancer’s resistance to treatment
Researchers at Baylor College of Medicine have developed an experimental drug called CS18 that may help cancer treatments work against tumors that have become resistant to therapy. The study, published in Science Advances, provides early evidence supporting further investigation of CS18 as a possible future cancer treatment. “Therapeutic resistance is a main obstacle to achieve … Read more